Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
DSM's venture capital arm has invested $2 million in Sol-Gel Technologies. The Israeli company's sol-gel technology enables room-temperature entrapment of organic and bioactive molecules in silica glass beads. According to DSM, delivery of the trapped ingredients can be controlled, a potentially valuable innovation for the pharmaceutical and cosmetic markets.
This article has been sent to the following recipient: